Heyman Richard A. insider trades
Heyman Richard A. has filed 47 Form 4s with the SEC that we hold, for Enliven Therapeutics, Inc. (ELVN) (Director), Oric Pharmaceuticals, Inc. (ORIC) (Director), PMV Pharmaceuticals, Inc. (PMVP) (Director) and GRTS (Director), among 6 companies in all. Across all of them we count 0 purchases worth $0 and 45 sales worth $1.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 13 sales ($741.4K). The largest single trade was a sale of 8,015 shares of Enliven Therapeutics, Inc. worth $200.7K, dated 2026-01-08. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-23 and the latest 2026-10-02.
Enliven Therapeutics, Inc. (ELVN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-12-19 | S, sale reported on Form 4 | 255 | $3.3K | 2023-12-21 |
| 2023-12-20 | S, sale reported on Form 4 | 1,915 | $24.9K | 2023-12-21 |
| 2023-12-20 | S, sale reported on Form 4 | 2,110 | $27.5K | 2023-12-21 |
| 2023-12-21 | S, sale reported on Form 4 | 7 | $91 | 2023-12-26 |
| 2023-12-21 | S, sale reported on Form 4 | 6 | $78 | 2023-12-26 |
| 2023-12-22 | S, sale reported on Form 4 | 168 | $2.2K | 2023-12-26 |
| 2023-12-22 | S, sale reported on Form 4 | 35 | $455 | 2023-12-26 |
| 2024-01-30 | S, sale reported on Form 4 | 1,270 | $20.8K | 2024-02-01 |
| 2024-02-15 | S, sale reported on Form 4 | 1,270 | $22.1K | 2024-02-20 |
| 2024-03-19 | S, sale reported on Form 4 | 1,270 | $18.4K | 2024-03-21 |
| 2024-04-11 | S, sale reported on Form 4 | 649 | $16.2K | 2024-04-15 |
| 2024-04-11 | S, sale reported on Form 4 | 5,045 | $126.3K | 2024-04-15 |
| 2024-04-15 | S, sale reported on Form 4 | 1,190 | $23.7K | 2024-04-15 |
| 2024-04-15 | S, sale reported on Form 4 | 80 | $1.7K | 2024-04-15 |
| 2024-05-16 | S, sale reported on Form 4 | 1,270 | $30.1K | 2024-05-20 |
| 2024-06-17 | S, sale reported on Form 4 | 1,270 | $27.3K | 2024-06-20 |
| 2024-07-15 | S, sale reported on Form 4 | 1,270 | $31.5K | 2024-07-17 |
| 2024-07-31 | S, sale reported on Form 4 | 649 | $17.8K | 2024-08-02 |
| 2024-07-31 | S, sale reported on Form 4 | 1,702 | $46.8K | 2024-08-02 |
| 2024-08-15 | S, sale reported on Form 4 | 650 | $14.8K | 2024-08-19 |
| 2024-08-15 | S, sale reported on Form 4 | 620 | $14.7K | 2024-08-19 |
| 2024-09-16 | S, sale reported on Form 4 | 1,270 | $28.5K | 2024-09-18 |
| 2024-10-01 | S, sale reported on Form 4 | 518 | $14.3K | 2024-10-03 |
| 2024-10-04 | S, sale reported on Form 4 | 2,825 | $77.7K | 2024-10-08 |
| 2024-10-15 | S, sale reported on Form 4 | 1,270 | $35.1K | 2024-10-17 |
| 2024-10-18 | S, sale reported on Form 4 | 753 | $22.6K | 2024-10-22 |
| 2024-10-18 | S, sale reported on Form 4 | 817 | $24.5K | 2024-10-22 |
| 2026-01-08 | S, sale reported on Form 4 | 8,015 | $200.7K | 2026-01-12 |
| 2026-01-08 | S, sale reported on Form 4 | 1,620 | $40.5K | 2026-01-12 |
| 2026-01-09 | S, sale reported on Form 4 | 4,285 | $107.1K | 2026-01-12 |
| 2026-01-20 | S, sale reported on Form 4 | 512 | $13.5K | 2026-01-22 |
| 2026-01-20 | S, sale reported on Form 4 | 718 | $19.4K | 2026-01-22 |
| 2026-02-17 | S, sale reported on Form 4 | 1,230 | $32.2K | 2026-02-19 |
Oric Pharmaceuticals, Inc. (ORIC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-07 | S, sale reported on Form 4 | 1,086 | $27.3K | 2021-09-09 |
| 2021-09-10 | S, sale reported on Form 4 | 479 | $12.0K | 2021-09-14 |
| 2021-09-13 | S, sale reported on Form 4 | 601 | $15.0K | 2021-09-14 |
| 2021-09-14 | S, sale reported on Form 4 | 706 | $17.7K | 2021-09-16 |
| 2021-09-15 | S, sale reported on Form 4 | 682 | $17.1K | 2021-09-16 |
| 2026-01-16 | S, sale reported on Form 4 | 3,200 | $38.4K | 2026-01-20 |
| 2026-01-16 | S, sale reported on Form 4 | 3,500 | $42.0K | 2026-01-20 |
| 2026-07-06 | S, sale reported on Form 4 | 300 | $3.6K | 2026-07-08 |
| 2026-07-24 | S, sale reported on Form 4 | 7,000 | $84.1K | 2026-07-28 |
| 2026-07-24 | S, sale reported on Form 4 | 6,100 | $73.3K | 2026-07-28 |
| 2026-10-01 | S, sale reported on Form 4 | 3,500 | $45.2K | 2026-10-02 |
| 2026-10-01 | S, sale reported on Form 4 | 3,200 | $41.3K | 2026-10-02 |
PMV Pharmaceuticals, Inc. (PMVP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
GRTS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MTCR
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RYZB
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1584759) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms